The Hidden Danger of Green Smoothies: Oxalate Overload
Recent headlines describing an ominous poisoning shed light on a lesser-known health risk lurking in everyday health fads: oxalate toxicity. While the story of a jilted lover who used ethylene glycol (commonly found in antifreeze) to harm his lover may seem far-fetched, the aftermath—a cascade of oxalate crystal deposits that wreak havoc on the victim’s kidneys and liver—serves as a stark reminder. the dangers posed by oxalate-rich substances.
The underwater magic of green smoothies
Amid the fervor of health-focused trends, the ubiquitous “green smoothie” has emerged as a seemingly virtuous elixir. A quick online search brings up a plethora of recipes extolling the virtues of mixing nutrient-dense greens like spinach, kale, Swiss chard and arugula with berries or almonds for alleged health boosts. Yet, unbeknownst to many, these seemingly healthy concoctions harbor a hidden danger: oxalate overload.
The oxalate conundrum revealed
Oxalate, a compound prevalent in certain foods, fungal infections, and even human metabolism, poses a significant threat when consumed in excess. Oxalates, which are abundant in vegetables such as spinach, beets and nuts, can accumulate in the body, leading to a myriad of health problems.
Danger of oxalate overload
Excessive consumption of oxalates has been linked to kidney stones, a painful condition that affects millions of people worldwide. While calcium oxalate stones are a well-known consequence, oxalate’s insidious effects extend beyond the urinary tract. Oxalate crystals can infiltrate various tissues, causing inflammation, oxidative damage, and even compromising bone health and immune function.
Revealing the culprits: Foods high in oxalate
Many seemingly harmless foods are high in oxalates, including leafy greens, berries, nuts, tea and chocolate. While these staples may seem harmless, their cumulative amount of oxalates can spell trouble for susceptible individuals.
Mitigating oxalate overload entails a multifaceted approach:
- Risk Reduction: Strategies for Oxalate Control
- Alleviating oxalate overload requires a multi-pronged approach:
- Addressing fungal overgrowth: Antifungal treatment can help fight fungal infections that are involved in oxalate production, especially in conditions like autism.
- Supplemental Support: Calcium citrate and magnesium citrate supplements help reduce oxalate absorption, while chondroitin sulfate helps prevent calcium oxalate crystal formation.
- Vitamin B6 supplementation: Vitamin B6 acts as a cofactor in oxalate degradation, thereby limiting oxalate production.
- Adopting a low-oxalate diet: Limiting high-oxalate foods moderates oxalate intake and offers relief from symptoms associated with oxalate toxicity.
- Hydration: Adequate water intake facilitates the excretion of oxalates and reduces the burden on the kidneys.
Toxicity assessment of oxalates: Organic acid test
The Organic Acid Test (OAT) is proving to be a valuable tool for measuring oxalate toxicity, offering insight into genetic predispositions, nutritional imbalances, and fungal overgrowth that contribute to oxalate overload.
Conclusion: Navigating the risks of health fads
While the allure of green smoothies can be exciting, the hidden danger of oxalate overload underscores the importance of making informed dietary choices. By adopting a balanced approach to nutrition and heeding the warning signs of oxalate toxicity, individuals can protect their health and well-being amid an ever-evolving landscape of health trends.
References
Kohmani EF. Oxalic acid in foods and its behavior and fate in the diet. Journal of Nutrition. (1939) 18(3):233-246,1939
Tsao G. Production of oxalic acid by a wood-rotting fungus. Appl Microbiol. (1963) May; 11(3): 249-254.
Takeuchi H, Konishi T, Tomoyoshi T. Observation on fungi within urinary stones. Hinyokika Kiyo. (1987) May;33(5):658-61.
Lee SH, Barnes WG, Schaetzel WP. Pulmonary aspergillosis and the importance of oxalate crystal recognition in cytology specimens. Arch Pathol Lab Med. (1986) Dec;110(12):1176-9.
Muntz FH. Oxalate-producing pulmonary aspergillosis in an alpaca. Vet Pathol. (1999) Nov;36(6):631-2.
Loewus FA, Saito K, Suto RK, Maring E. Conversion of D-arabinose to D-erythroascorbic acid and oxalic acid in Sclerotinia sclerotiorum. Biochem Biophys Res Commun. (1995) Jul 6;212(1):196-203.
Fomina M, Hillier S, Charnock JM, Melville K, Alexander IJ, Gadd GM. Role of oxalic acid overexcretion in transformations of toxic metal minerals by Beauveria caledonica. Appl Environ Microbiol. (2005) Jan;71(1):371-81.
Ruijter GJG, van de Vondervoort PJI, Visser J. Oxalic acid production by Aspergillus niger: an oxalate-non-producing mutant produces citric acid at pH 5 and in the presence of manganese. Microbiology (1999) 145, 2569–2576.
Ghio AJ, Peterseim DS, Roggli VL, Piantadosi CA. Pulmonary oxalate deposition associated with Aspergillus niger infection. An oxidant hypothesis of toxicity. Am Rev Respir Dis. (1992) Jun;145(6):1499-502.
Takeuchi H, Konishi T, Tomoyoshi T. Detection by light microscopy of Candida in thin sections of bladder stone. Urology. (1989) Dec;34(6):385-7.
Ghio AJ, Roggli VL, Kennedy TP, Piantadosi CA. Calcium oxalate and iron accumulation in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. (2000) Jun;17(2):140-50.
Ott SM, Andress DL, Sherrard DJ. Bone oxalate in a long-term hemodialysis patient who ingested high doses of vitamin C. Am J Kidney Dis. (1986) Dec;8(6):450-4.
Hall BM, Walsh JC, Horvath JS, Lytton DG. Peripheral neuropathy complicating primary hyperoxaluria. J Neurol Sci. (1976) Oct;29(2-4):343-9.
Sahin G, Acikalin MF, Yalcin AU. Erythropoietin resistance as a result of oxalosis in bone marrow. Clin Nephrol. (2005) May;63(5):402-4.
Sarma AV, Foxman B, Bayirli B, Haefner H, Sobel JD. Epidemiology of vulvar vestibulitis syndrome: an exploratory case-control study. Sex Transm Infect. (1999) Oct;75(5):320-6.
http://wisewitch.blogspot.com/2006/07/guaifenesinfibromyalgia-and-oxalates.html
http://www.diagnoseme.com/cond/C510175.html
http://www.vulvarpainfoundation.org/Lowoxalatetreatment.htm
Fishbein GA, Micheletti RG, Currier JS, Singer E, Fishbein MC. Atherosclerotic oxalosis in coronary arteries. Cardiovasc Pathol. (2008) ; 17(2): 117–123.
Levin RI, PW Kantoff, EA Jaffe. Uremic levels of oxalic acid suppress replication and migration of human endothelial cells. Arterioscler Thromb Vasc Biol (1990), 10:198-207
Di Pasquale G, Ribani M, Andreoli A, Angelo Zampa G, Pinelli G. Cardioembolic stroke in primary oxalosis with cardiac involvement. Stroke (1989), 20:1403-1406.
Ziolkowski F, Perrin DD. Dissolution of urinary stones by calcium-chelating agents: A study using a model system. Invest Urol. (1977) Nov;15(3):208-11.
Burns JR, Cargill JG 3rd. Kinetics of dissolution of calcium oxalate calculi with calcium-chelating irrigating solutions. J Urol. (1987) Mar;137(3):530-3.
http://www.greatplainslaboratory.com/home/eng/oxalates.asp
Kaminishi H, Hagihara Y, Hayashi S, Cho T. Isolation and characteristics of collagenolytic enzyme produced by Candida albicans. Infect Immun. (1986) August; 53(2): 312–316.
Shirane Y, Kurokawa Y, Miyashita S, Komatsu H, Kagawa S. Study of inhibition mechanisms of glycosaminoglycans on calcium oxalate monohydrate crystals by atomic force microscopy. Urol Res. (1999) Dec; 27(6):426-31.
Chetyrkin SV, Kim D, Belmont JM, Scheinman JI, Hudson BG, Voziyan PA. Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria. Kidney Int. (2005) Jan;67(1):53-60.
Morrison C. Ditch healthy berries to beat muscle pain: The eating plan that helped me cure my aches and pains. The Daily Mail Online. August 13, 2012. http://www.dailymail.co.uk/health/article-2187890/Ditch-healthy-berries-beat-muscle-pain-The-eating-plan-helped-cure-aches-pains.html. (Accessed November 21, 2014)